bezafibrate has been researched along with Recrudescence in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banda, K; Bunce, CM; Drayson, MT; Dunn, JA; Iqbal, G; Khanim, FL; Merrick, B; Molyneux, E | 1 |
| Bunce, CM; Craddock, CF; Drayson, MT; Hayden, RE; Holyoake, TL; Jackson, N; Khanim, FL; Lumley, M; Murray, JA | 1 |
| Battler, A; Behar, S; Benderly, M; Boyko, V; Fisman, EZ; Goldbourt, U; Haim, M; Matas, Z; Tanne, D; Tenenbaum, A; Zimmlichman, R | 1 |
| Ishiwata, S; Nakanishi, S; Nishiyama, S; Seki, A | 1 |
| Ericsson, CG | 1 |
| Kanaki, T; Saito, Y | 1 |
| Gang, N; Langevitz, P; Livneh, A | 1 |
2 review(s) available for bezafibrate and Recrudescence
| Article | Year |
|---|---|
Results of the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and an update on trials now in progress.
Topics: Adult; Bezafibrate; Cholesterol; Coronary Artery Disease; Disease Progression; Double-Blind Method; Humans; Hypolipidemic Agents; Male; Myocardial Infarction; Recurrence; Treatment Outcome; Triglycerides | 1998 |
[Anti-atherogenic drugs].
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Bezafibrate; Coronary Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Probucol; Recurrence; Syndrome | 1998 |
5 trial(s) available for bezafibrate and Recrudescence
| Article | Year |
|---|---|
Bezafibrate and medroxyprogesterone acetate in resistant and relapsed endemic Burkitt lymphoma in Malawi; an open-label, single-arm, phase 2 study (ISRCTN34303497).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Burkitt Lymphoma; Child; Child, Preschool; Drug Resistance, Neoplasm; Endemic Diseases; Female; Humans; Malawi; Male; Medroxyprogesterone Acetate; Recurrence | 2014 |
Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bezafibrate; Female; Hematologic Diseases; Humans; Leukemia, Myeloid, Acute; Male; Medroxyprogesterone Acetate; Middle Aged; Recurrence; Treatment Outcome | 2010 |
C-reactive protein, bezafibrate, and recurrent coronary events in patients with chronic coronary heart disease.
Topics: Bezafibrate; C-Reactive Protein; Coronary Disease; Death, Sudden, Cardiac; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Recurrence; Risk Factors | 2007 |
Prevention of restenosis by bezafibrate after successful coronary angioplasty.
Topics: Angioplasty, Balloon, Coronary; Bezafibrate; Cholesterol, HDL; Constriction, Pathologic; Coronary Disease; Female; Humans; Hypolipidemic Agents; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Recurrence; Treatment Outcome; Triglycerides | 1995 |
Results of the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and an update on trials now in progress.
Topics: Adult; Bezafibrate; Cholesterol; Coronary Artery Disease; Disease Progression; Double-Blind Method; Humans; Hypolipidemic Agents; Male; Myocardial Infarction; Recurrence; Treatment Outcome; Triglycerides | 1998 |
1 other study(ies) available for bezafibrate and Recrudescence
| Article | Year |
|---|---|
Relapsing acute pancreatitis induced by re-exposure to the cholesterol lowering agent bezafibrate.
Topics: Acute Disease; Aged; Anticholesteremic Agents; Bezafibrate; Drug Hypersensitivity; Female; Humans; Hypercholesterolemia; Multiple Organ Failure; Pancreatitis; Recurrence | 1999 |